Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Anna A. Rybczynska"'
Autor:
T. Jeroen N. Hiltermann, Pei Meng, Jiacong Wei, Martijn Terpstra, Ali Saber, Klaas Kok, Wim Timens, Ed Schuuring, Jantine Sietzema, Anna A. Rybczynska, Anke van den Berg, Anthonie J. van der Wekken, Harry J.M. Groen
Publikováno v:
Cancers, 12(10):2843, 1-17. MDPI AG
Cancers
Cancers, Vol 12, Iss 2843, p 2843 (2020)
Volume 12
Issue 10
Cancers
Cancers, Vol 12, Iss 2843, p 2843 (2020)
Volume 12
Issue 10
The number of genomic aberrations known to be relevant in making therapeutic decisions for non-small cell lung cancer patients has increased in the past decade. Multiple molecular tests are required to reliably establish the presence of these aberrat
Autor:
Kiichi Ishiwata, Chantal Kwizera, Csaba Nyakas, Nisha K. Ramakrishnan, Aren van Waarde, Rudi Dierckx, Jurgen W. A. Sijbesma, Anniek K. D. Visser, Anna A. Rybczynska, Paul G.M. Luiten, Philip H. Elsinga
Publikováno v:
Molecular Imaging and Biology
Molecular Imaging and Biology, 18(4), 588-597. SPRINGER
Molecular Imaging and Biology, 18(4), 588-597. SPRINGER
Purpose Sigma-1 receptor ligands modulate the release of several neurotransmitters and intracellular calcium signaling. We examined the binding of a radiolabeled sigma-1 agonist in the aging rat brain with positron emission tomography (PET). Procedur
Autor:
Rudi Dierckx, Philip H. Elsinga, Nisha Kuzhuppilly Ramakrishnan, Kiichi Ishiwata, Aren van Waarde, Anna A. Rybczynska
Publikováno v:
Biochimica et Biophysica Acta (BBA) - Biomembranes. 1848(10):2703-2714
Sigma receptors (sigma-1 and sigma-2) represent two independent classes of proteins. Their endogenous ligands may include the hallucinogen N,N-dimethyltryptamine (DMT) and sphingolipid-derived amines which interact with sigma-1 receptors, besides ste
Autor:
Aren van Waarde, Walter Noordzij, Rudi Dierckx, Hendrikus H. Boersma, Jourik A. Gietema, Anna A. Rybczynska, Steven de Jong, Philip H. Elsinga
Publikováno v:
Medicinal Research Reviews
Successful treatment of cancer patients requires balancing of the dose, timing, and type of therapeutic regimen. Detection of increased cell death may serve as a predictor of the eventual therapeutic success. Imaging of cell death may thus lead to ea
Autor:
A. J. van der Wekken, Ed Schuuring, Harry J.M. Groen, Jiacong Wei, M. M. Terpstra, Thijo J N Hiltermann, Ali Saber, Wim Timens, Klaas Kok, A.M. van den Berg, Anna A. Rybczynska
Publikováno v:
Annals of Oncology, 28. Oxford University Press
Autor:
Rudi Dierckx, Lachlan S. Campbell-Verduyn, Philippus Elsinga, Bernard Feringa, Anna A. Rybczynska, Leila Mirfeizi, Aren van Waarde
Publikováno v:
Nuclear Medicine and Biology, 41(2), 203-209. ELSEVIER SCIENCE INC
Cerebral β‐adrenergic receptors (β‐ARs) play important roles in normal brain and changes of β-AR expression are associated with several neuropsychiatric illnesses. Given the high density of β‐AR in several brain regions, quantification of
Autor:
A. J. van der Wekken, Klaas Kok, Thijo J N Hiltermann, Pei Meng, A. P. van den Berg, Anna A. Rybczynska, Ed Schuuring, Wim Timens, Harry J.M. Groen, Jiacong Wei, M. M. Terpstra
Publikováno v:
Annals of Oncology, 30:UNSP mdz413.025. Oxford University Press
Background The detection of driver aberrations such as EGFR and ALK, in tumour tissue or plasma has become important for treating lung cancer patients. The aim of this study is to explore the feasibility of detecting therapy-guiding aberrations in RN
Autor:
Harry J.M. Groen, Jiacong Wei, Anthonie J. van der Wekken, Klaas Kok, Jeroen Hiltermann, Anke van den Berg, Anna A. Rybczynska, Pei Meng, Ed Schuuring, Martijn Terpstra
Publikováno v:
Cancer Research. 79:2989-2989
Background. In the past decade, treatment of advanced stage lung cancer patients guided by somatic aberrations has become routine practice. Different molecular tests are being applied to detect all targetable mutations and fusions. However, in most c
Autor:
Johan R. de Jong, Rudi Dierckx, Nisha Kuzhuppilly Ramakrishnan, Wijnand Helfrich, Philip H. Elsinga, Anna A. Rybczynska, Aren van Waarde, Marco de Bruyn
Publikováno v:
Journal of Nuclear Medicine, 54(9), 1613-1620. SOC NUCLEAR MEDICINE INC
sigma-ligands can kill tumor cells. Previously we have shown that a short in vitro incubation of C6 tumor cells with sigma-ligands (24 h) results in a dose-dependent increase of cellular F-18-FDG uptake and that the magnitude of this increase is pred
Autor:
Jan Pruim, Rudi Dierckx, Anna A. Rybczynska, Jurgen W. A. Sijbesma, Chantal Kwizera, Krisztina Marosi, Philip H. Elsinga, Csaba Nyakas, Aren van Waarde, Anniek K. D. Visser, Kiichi Ishiwata, Nisha Kuzhuppilly Ramakrishnan
Publikováno v:
Journal of Nuclear Medicine, 54(8), 1377-1383. SOC NUCLEAR MEDICINE INC
Pituitary tumors are often detected only after death or at late stages of the disease when they are macroadenomas with a low surgical cure rate. Spontaneous pituitary tumors occur in rats over 1 y of age. In an ongoing study of changes in sigma-1 ago